IBM stock surged last year as the tech giant's strategy started to pay off. The AI business is booming, and IBM boosted its outlook as a result. The company laid out a detailed quantum computing ...

CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

Jumble has been entertaining folks since 1954 and has been a classic game where scrambled words require you to unscramble them in order to find key letters that leads to a final word to be unscrambled ...

Scientists had a rough year in 2025. As always, experts from all disciplines arrived at some groundbreaking conclusions, a small but critical portion of which we’ve highlighted in our annual Gizmodo ...

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

The last full trading week before Christmas could be a busy one. Key economic data that was delayed by the shutdown is due, including the jobs report and the consumer-price index for November. A ...

IBM (IBM) revealed today it plans to acquire Confluent (CFLT), a pioneer in data streaming, for about $11B, prompting Confluent shares to surge more than 25% during early Monday trading. Confluent ...

OpenAI is reportedly operating under a "code red" to deploy improvements to ChatGPT so the chatbot can better compete with Google's Gemini 3 model released last month. A few reports early last week ...

IBM has agreed to acquire cloud-native enterprise data streaming platform Confluent in a move designed to expand its portfolio of tools for building AI applications The company said Monday in a ...

Editor's take: Normal people are now shelling out hundreds of dollars for modest RAM upgrades, while the companies powering the AI boom are looking forward to even more market hysteria. And despite ...

In my last note on Altimmune, Inc. (ALT) shared in late August, I made the bull case for its stock. I discussed the Gaithersburg, Maryland based biotech's lead and only drug candidate, pemvidutide, ...